- A new Medicare pilot called "GLP‑1 Bridge" starts July 1 letting many seniors get popular weight‑loss drugs (Wegovy, Zepbound, Foundayo) for a $50 monthly copay — a steep discount from hundreds or even $1,000+ a month.
- Not everyone qualifies: the program has specific BMI and health‑condition rules and excludes people already getting GLP‑1s through Part D or those with type 2 diabetes, leaving some hopeful seniors disappointed or confused.
- It’s temporary (through the end of 2027) as CMS tests payment models, so long‑term coverage is still uncertain and insurers’ participation after the pilot is unclear.
The news, distilled into what matters.
Get the full experience in the app — topics, comments, and audio summaries.